[´º½º·±=¼Ò¹ÎÈñ ±âÀÚ] ¢ßÇ︯½º¹Ì½º´Â 2019³â 2¿ù 2ÀÏ~5ÀÏ¿¡ °ÉÃÄ ¹Ì±¹ ÄݷζóµµÁÖ Å°½ºÅæ(Keystone)¿¡¼ ¿¸± Å°½ºÅæ ½ÉÆ÷Áö¿ò(Pain: Aligning the Target)¿¡¼ VM202ÀÇ ÀÓ»ó½ÃÇè ¹× ¿¬±¸ °á°ú¸¦ ÃÑ 3°Ç ¹ßÇ¥ÇÑ´Ù. ¿ø·¡´Â ÀÓ»ó½ÃÇè °á°ú 1°Ç¸¸À» ¼Ò°³ÇÒ ¿¹Á¤À̾úÀ¸³ª, ÀÌ¿Ü¿¡µµ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ 2°ÇÀÇ ´Ù¸¥ ÁÖÁ¦µµ °ø°³Çϱâ·Î °áÁ¤ÇÑ °ÍÀÌ´Ù. ÀÌ ¹ßÇ¥ÀÇ ³»¿ëÀº ³»³â 1¿ù °æ ½ÉÆ÷Áö¿ò À¥»çÀÌÆ®¿¡ °ø°³µÉ ¿¹Á¤ÀÌ´Ù. ¹ßÇ¥ Á¦¸ñÀº ´ÙÀ½°ú °°´Ù.
➀ Á¦¸ñ: New Concept Regenerative Medicine for Neuropathic Pain Using Plasmid DNA Encoding Human Hepatocyte Growth Factor (HGF), Engensis®(VM202): Scientific Basis and Results from Clinical Studies
(HGF¸¦ ¹ßÇöÇÏ´Â Çö󽺹̵å DNA[¿£Á¨½Ã½º(VM202)]¸¦ È°¿ëÇÑ ½Å°³³ä ÅëÁõ¼º ½Å°æº´Áõ Ä¡·áÁ¦ °³¹ß: °úÇÐÀû ±Ù°Å¿Í ÀÓ»ó½ÃÇè °á°ú)
➁ Á¦¸ñ: Gabapentin, a calcium channel inhibitor, inhibits nerve regeneration process induced by hepatocyte growth factor (HGF) in in vivo and in vitro: Implication for the use of gabapentinoids as analgesics for peripheral neuropathy.
(°£¼¼Æ÷¼ºÀåÀÎÀÚ¿¡ ÀÇÇØ À¯µµµÇ´Â ½Å°æ Àç»ý°úÁ¤¿¡ ´ëÇÑ °¡¹ÙÆæƾÀÇ ¹æÇØÀÛ¿ë: ¸»ÃʽŰ溴Áõ¿¡ ´ëÇÑ ÁøÅëÁ¦·Î½á °¡¹ÙÆæƼ³ëÀ̵åÀÇ »ç¿ë¿¡ ´ëÇÑ ÀǹÌ)
¼Ò¹ÎÈñ ±âÀÚ news114 @newsrun.co.kr
¼Ò¹ÎÈñ ±âÀÚ news114 @newsrun.co.kr
<ÀúÀÛ±ÇÀÚ © ´º½º·±, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>